MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • Patient Community Day at MSToronto2026
  • The ECTRIMS Podcast at MSToronto2026
  • Antiviral Reverses Disability in Mouse Model of MS
  • Assessing & Monitoring Cognition in MS
  • Potential Changes to MS Treatment Access in Australia
  • MS Auckland Webinar: AHSCT as a Treatment for MS
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Tagged Research

Environmental Factors & MS-related Genes

MStranslate
September 30, 2015
Genetics, Research
The development of the International MS Genetics Consortium has led to the identification of more than 159 genetic variants that are associated with...

Cumulative Genetic Risk Score in People with MS

MStranslate
September 24, 2015
Genetics, Research
We recently conducted an interview with A/Prof An Goris (left) and Ph.D. student Kelly Hilven (right) from the Laboratory for Neuroimmunology at...
Stem Cell Therapy

Evaluating Stem Cell Therapy for Progressive MS

MStranslate
September 22, 2015
Research, Stem Cells, Treatments
A publication this week in BMJ Open has outlined a number of studies evaluating the use of stem cell therapy for people with progressive multiple...

New Insights into Neuropathic Pain

MStranslate
September 3, 2015
Research
Neuropathic pain is a serious symptom experienced by many people with multiple sclerosis that can result in abnormal sensations (e.g. tingling and...

Vitamin D, Oestrogen & Multiple Sclerosis

MStranslate
August 31, 2015
Hormones, Lifestyle, Research, Vitamin D
The fact that after puberty women get MS more than men indicates a potential role for female sex hormones in the development of the disease. The fact...
Clinical Trial

MIS416: A Clinical Trial for Secondary Progressive MS

MStranslate
August 26, 2015
Clinical Trials, Research, Treatments
Due to the lack of available treatment options for people with secondary progressive multiple sclerosis (SPMS), the development of novel therapies...
Fatigue

Fatigue, Melatonin & MS

MStranslate
August 24, 2015
Fatigue, Lifestyle, Research, Symptoms
Fatigue is one of the most common symptoms associated with multiple sclerosis (MS) and is often the one that has the biggest impact on quality of...
Human Endogenous Retroviruses

Human Endogenous Retroviruses & MS

MStranslate
August 4, 2015
Collaboration, Research
Dr John Kriesel, head of the Kriesel Lab at the University of Utah, provides an overall introduction to his team.  In particular, he discusses...
Multiple Sclerosis

Diet and Multiple Sclerosis

MStranslate
July 27, 2015
Diet, Lifestyle, Research
We all know that a healthy diet is important for our well-being, but does it differ for people with multiple sclerosis? As something that can be...
Secretogranin-1

Secretogranin-1: A Potential New Biomarker for MS

MStranslate
July 16, 2015
Research
Recent studies have shown that early administration of therapies lead to better long-term outcomes for people with multiple sclerosis (MS)....
  1. 16
  2. 17
  3. 18
  4. 19
  5. 20
  6. 21
  7. 22

Recent Posts

  • Patient Community Day at MSToronto2026
  • The ECTRIMS Podcast at MSToronto2026
  • Antiviral Reverses Disability in Mouse Model of MS
  • Assessing & Monitoring Cognition in MS
  • Potential Changes to MS Treatment Access in Australia

Recent Comments

  • Patient Community Day at MSToronto2026 on The ECTRIMS Podcast at MSToronto2026
  • MStranslate on Multiple Sclerosis Research In 2026
  • MStranslate on Multiple Sclerosis Research In 2026
  • K on Multiple Sclerosis Research In 2026
  • Mohammad on Multiple Sclerosis Research In 2026

Calendar

November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
« Sep    

Archives

Categories

Posts

  • Patient Community Day at MSToronto2026
  • The ECTRIMS Podcast at MSToronto2026
  • Antiviral Reverses Disability in Mouse Model of MS
  • Assessing & Monitoring Cognition in MS
  • Potential Changes to MS Treatment Access in Australia

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.